Skip Navigation


Carcinogenesis Advance Access originally published online on July 7, 2004
Carcinogenesis 2004 25(11):2089-2100; doi:10.1093/carcin/bgh227
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/11/2089    most recent
bgh227v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tacchini, L.
Right arrow Articles by Desiderio, M.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tacchini, L.
Right arrow Articles by Desiderio, M.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.11 © Oxford University Press 2004; all rights reserved.

ARTICLE

Hepatocyte growth factor-activated NF-{kappa}B regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines

L. Tacchini, C. De Ponti, E. Matteucci, R. Follis and M.A. Desiderio1

Institute of General Pathology, University of Milan, Via Luigi Mangiagalli 31, 20133 Milan, Italy

1 To whom correspondence should be addressed. Tel: +39 0250315334; Fax: +39 0250315338; Email: a.desiderio{at}unimi.it

Hepatocyte growth factor (HGF)-stimulated Met signaling influences tumor survival, growth and progression, all processes involving the transcription factor NF-{kappa}B. NF-{kappa}B plays a complex role in the control of survival due to the influence of cellular factors acting downstream. We undertook a comparative investigation of two human breast carcinoma cells with different grades of malignancy and HepG2 hepatoma cells, which present a biphasic response to HGF (proliferation followed by apoptosis). We found evidence that HGF induced gene patterns characteristic of survival rather than apoptosis depending on the cell type. The ability of NF-{kappa}B to regulate expression of hypoxia-inducible factor-1{alpha} (HIF-1{alpha}), a survival/anti-apoptotic gene in cancer, seemed to be critical. In the HepG2 and MCF-7 (low invasive breast carcinoma) cell lines increased transcription and translation were responsible for HIF-1{alpha} induction after HGF. The regulation by NF-{kappa}B was mainly at the level of the 5'-UTR of the HIF-1{alpha} message. HIF-1 ({alpha} heterodimer) was likely to transactivate Mcl-1, another anti-apoptotic gene. Opposite results were observed in MDA-MB-231 cells (highly invasive breast carcinoma), which have high NF-{kappa}B activity, further inducible by HGF, because HIF-1{alpha} mRNA expression and HIF-1 transactivating capacity were HGF-insensitive while the {alpha} subunit seemed to be degraded after HGF. However, ornithine decarboxylase (ODC) and heme oxygenase mRNA expression persistently increased. By transiently transfecting two ODC gene reporters we demonstrated that ODC is a target gene of NF-{kappa}B in HGF-treated tumor cells. By regulating HIF-1 activity and specific gene expression downstream, NF-{kappa}B may influence the survival threshold, with an impact on the fate of carcinoma cells after prolonged HGF treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
C. T. Taylor
Interdependent roles for hypoxia inducible factor and nuclear factor-{kappa}B in hypoxic inflammation
J. Physiol., September 1, 2008; 586(17): 4055 - 4059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo
Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals
J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Tillmanns, M. Rota, T. Hosoda, Y. Misao, G. Esposito, A. Gonzalez, S. Vitale, C. Parolin, S. Yasuzawa-Amano, J. Muraski, et al.
Formation of large coronary arteries by cardiac progenitor cells
PNAS, February 5, 2008; 105(5): 1668 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Sourbier, S. Danilin, V. Lindner, J. Steger, S. Rothhut, N. Meyer, D. Jacqmin, J.-J. Helwig, H. Lang, and T. Massfelder
Targeting the Nuclear Factor-{kappa}B Rescue Pathway Has Promising Future in Human Renal Cell Carcinoma Therapy
Cancer Res., December 15, 2007; 67(24): 11668 - 11676.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Canas, T. Valero, M. Villarroya, E. Montell, J. Verges, A. G. Garcia, and M. G. Lopez
Chondroitin Sulfate Protects SH-SY5Y Cells from Oxidative Stress by Inducing Heme Oxygenase-1 via Phosphatidylinositol 3-Kinase/Akt
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. S. BelAiba, S. Bonello, C. Zahringer, S. Schmidt, J. Hess, T. Kietzmann, and A. Gorlach
Hypoxia Up-Regulates Hypoxia-Inducible Factor-1{alpha} Transcription by Involving Phosphatidylinositol 3-Kinase and Nuclear Factor {kappa}B in Pulmonary Artery Smooth Muscle Cells
Mol. Biol. Cell, December 1, 2007; 18(12): 4691 - 4697.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. Matteucci, E. Ridolfi, P. Maroni, P. Bendinelli, and M. A. Desiderio
c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells
Mol. Cancer Res., August 1, 2007; 5(8): 833 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. De Ponti, R. Carini, E. Alchera, M. P. Nitti, M. Locati, E. Albano, G. Cairo, and L. Tacchini
Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages
J. Leukoc. Biol., August 1, 2007; 82(2): 392 - 402.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Bonello, C. Zahringer, R. S. BelAiba, T. Djordjevic, J. Hess, C. Michiels, T. Kietzmann, and A. Gorlach
Reactive Oxygen Species Activate the HIF-1{alpha} Promoter Via a Functional NF{kappa}B Site
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Veschini, D. Belloni, C. Foglieni, M. G. Cangi, M. Ferrarini, F. Caligaris-Cappio, and E. Ferrero
Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib
Blood, March 15, 2007; 109(6): 2565 - 2570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. McMahon, M. Charbonneau, S. Grandmont, D. E. Richard, and C. M. Dubois
Transforming Growth Factor beta1 Induces Hypoxia-inducible Factor-1 Stabilization through Selective Inhibition of PHD2 Expression
J. Biol. Chem., August 25, 2006; 281(34): 24171 - 24181.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.